SABCS 2024 Insights: Comparative OS of CDK4/6 Inhibitors + Aromatase Inhibitors in HR+/HER2- mBC - Insights From US Real-World Setting | VuMedi

Find latest Breast Cancer videos · 1000+ videos

SABCS 2024 Insights: Comparative OS of CDK4/6 Inhibitors + Aromatase Inhibitors in HR+/HER2- mBC - Insights From US Real-World Setting

By 2024 SABCS Annual Meeting Insights Hub FEATURING Hope Rugo

By 2024 SABCS Annual Meeting Insights Hub FEATURING Hope Rugo

201 views

March 4, 2025

Comments 0

Login to view comments. Click here to Login